Risk of Hepatitis B Reactivation in Patients with Past Hepatitis B Virus Infection Undergoing Biologic and Targeted Therapies for Rheumatic Diseases

Risk of Hepatitis B Reactivation in Patients with Past Hepatitis B Virus Infection Undergoing Biologic and Targeted Therapies for Rheumatic Diseases

Studies from Asian and European countries have demonstrated a low risk of hepatitis B virus (HBV) reactivation in patients with past hepatitis B infection (HBsAg −ve, anti-HBc [Formula: see text]ve) and rheumatic diseases receiving biological and targeted synthetic disease-modifying antirheumatic dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin Man Ho Chung, Judy Tze Lei Sham, Catherine Ka Yan Yuen, Suet Kei Kwok, Lai Man Tang, Carmen Tze Kwan Ho, Chi Chiu Mok
Format: Article
Language:English
Published: World Scientific Publishing 2025-07-01
Series:Journal of Clinical Rheumatology and Immunology
Subjects:
Hepatitis B
Antiviral
Biologics
JAK inhibitor
Reactivation
Online Access:https://www.worldscientific.com/doi/10.1142/S2661341725500014
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.worldscientific.com/doi/10.1142/S2661341725500014

Similar Items